(Q41488786)

1 October 2017

title

Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras. (English)

1 reference

1 October 2017

4

G Gaudernack

1 reference

1 October 2017

3

E Thorsby

1 reference

1 October 2017

T Gedde-Dahl

1

1 reference

1 October 2017

E Nilsen

series ordinal

2

1 reference

1 October 2017

publication date

1 February 1994

1 reference

Cancer Immunology, Immunotherapy

1 October 2017

published in

1 reference

1 October 2017

volume

38

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

127-134

1 reference

T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides

1 October 2017

cites work

1 reference

12 December 2020

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

12 December 2020

MHC class II-restricted presentation of intracellular antigen

1 reference

12 December 2020

Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens

1 reference

12 December 2020

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

1 reference

12 December 2020

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

1 reference

12 December 2020

The detailed distribution of HLA-A, B, C antigens in normal human organs

1 reference

12 December 2020

Rapid immunomagnetic phenotyping of cells.

1 reference

12 December 2020

Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

1 reference

12 December 2020

Expression of two distinct cytolytic mechanisms among murine CD4 subsets.

1 reference

12 December 2020

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).

1 reference

12 December 2020

Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein

1 reference

12 December 2020

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes

1 reference

12 December 2020

The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells.

1 reference

12 December 2020

Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).

1 reference

12 December 2020

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

12 December 2020

T-cell recognition of HLA class II molecules induced by gamma-interferon on a colonic adenocarcinoma cell line (HT29).

1 reference

12 December 2020

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

12 December 2020

High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis

1 reference

12 December 2020

MHC antigens on human tumors

1 reference

12 December 2020

Prevalence of ras gene mutations in human colorectal cancers

1 reference

12 December 2020

Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification

1 reference

12 December 2020

Presence of mutations in all three ras genes in human thyroid tumors

1 reference

12 December 2020

Expression of class I and II human leukocyte antigens by thyrocytes and lymphocytic infiltration on human thyroid tumors. An immunofluorescence study

1 reference

12 December 2020

Activated Val-12 ras p21 in cell culture fluids and mouse plasma

1 reference

12 December 2020

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

1 reference

12 December 2020

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 December 2020

Growth factor production by human colon carcinoma cell lines

1 reference

12 December 2020

Immunosuppressive factors in human cancer.

1 reference

12 December 2020

Class II MHC molecules can use the endogenous pathway of antigen presentation

1 reference

12 December 2020

Anti-tumour activity of idiotype-specific, MHC-restricted Th1 and Th2 clones in vitro and in vivo

1 reference

12 December 2020

Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis

1 reference

12 December 2020

Expression and Regulation of Adhesion Molecules ICAM-1 (CD54) and LFA-3 (CD58) in Human Intestinal Epithelial Cell Lines

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Induction of Various HLA Class II Molecules in a Human Colonic Adenocarcinoma Cell Line

1 reference

12 December 2020

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

12 December 2020

Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells

1 reference

12 December 2020

Characterization of an immunosuppressive factor derived from colon cancer cells

1 reference

12 December 2020

Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002620050045

1 reference

Dimensions Publication ID

1 October 2017

1054514105

0 references

1 reference